<DOC>
	<DOCNO>NCT02365584</DOCNO>
	<brief_summary>The primary objective study evaluate impact quality life Lanreotide Autogel 120 mg combination standard care , comparison standard care alone , subject affect inoperable malignant bowel obstruction .</brief_summary>
	<brief_title>Quality Life Patients With Inoperable Malignant Bowel Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Obstruction</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Subjects must demonstrate willingness participate study compliant protocol procedure . Provision write informed consent prior study related procedure . Diagnosis inoperable malignant bowel obstruction , confirm appropriate image report . In case peritoneal carcinomatosis , diagnostic confirmation CT MRI scan . Confirmed inoperable medical advice . Patient nasogastric tube present 3 episode vomit every day last consecutive 48 hour . Patient life expectancy must 14 day . Has operable obstruction subobstruction . Has bowel obstruction due nonmalignant cause ; ( hypokaliaemia , drug sideeffects , renal insufficiency , etc ) . Has sign bowel perforation . Has prior treatment somatostatin analogue within previous 60 day . Has know hypersensitivity study treatment related compound . Is likely require treatment study somatostatin analogue study treatment . Is risk pregnancy lactation , likely father child study . Females childbearing potential must provide negative pregnancy test start study must use oral double barrier contraception . Non childbearing potential define postmenopause least 1 year , surgical sterilisation hysterectomy least three month start study . Has mental condition render subject unable understand nature , scope possible consequence study , and/or evidence uncooperative attitude . Has abnormal baseline finding , medical condition ( ) laboratory finding , opinion Investigator , might jeopardise subject 's safety decrease chance obtain satisfactory data need achieve objective ( ) study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>